• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳糖酶治疗婴儿肠绞痛:一项随机临床试验的系统评价。

Lactase for infantile colic: A systematic review of randomized clinical trials.

机构信息

Division of Pediatric Gastroenterology, Hospital Jaraguá, Jaraguá do Sul, Brazil.

Universidade Municipal de São Caetano do Sul, São Caetano do Sul, Brazil.

出版信息

J Pediatr Gastroenterol Nutr. 2024 Oct;79(4):855-862. doi: 10.1002/jpn3.12231. Epub 2024 May 8.

DOI:10.1002/jpn3.12231
PMID:38720550
Abstract

Infantile colic is excessive crying for no apparent reason in an otherwise healthy infant. Although its physiopathology is not completely understood, therapies usually target gastrointestinal symptoms. This systematic review of randomized controlled trials (RCTs) analyzes the efficacy of lactase supplementation in infantile colic. PubMed, Embase, and Cochrane were searched for RCTs evaluating lactase supplementation in infants up to 6 months old with infantile colic. Out of six RCTs including 394 patients, three reported a significantly shorter crying time in the lactase group than in the placebo group, while the other three found no significant difference between groups. Of the two studies that performed the hydrogen breath test, only one reported a significant reduction in exhaled hydrogen levels. The pharmacological approach to infantile colic remains debatable, and new studies with standardized diagnostic criteria and outcomes are required to guide lactase supplementation in clinical practice.

摘要

婴儿肠绞痛是指健康婴儿无明显原因的过度哭闹。尽管其病理生理学尚未完全阐明,但治疗方法通常针对胃肠道症状。本系统评价对随机对照试验(RCT)进行分析,评估乳糖酶补充剂对婴儿肠绞痛的疗效。对评估婴儿肠绞痛的乳糖酶补充剂的 RCT 进行了 PubMed、Embase 和 Cochrane 检索,纳入的婴儿年龄为 6 个月以下。在纳入的 6 项 RCT 中,共 394 例患儿,其中 3 项研究表明乳糖酶组的哭闹时间显著短于安慰剂组,而另外 3 项研究则未发现组间差异。在进行氢呼气试验的两项研究中,仅有一项报道呼气氢水平显著降低。对于婴儿肠绞痛的药物治疗方法仍存在争议,需要新的研究采用标准化的诊断标准和结局来指导临床实践中乳糖酶的补充。

相似文献

1
Lactase for infantile colic: A systematic review of randomized clinical trials.乳糖酶治疗婴儿肠绞痛:一项随机临床试验的系统评价。
J Pediatr Gastroenterol Nutr. 2024 Oct;79(4):855-862. doi: 10.1002/jpn3.12231. Epub 2024 May 8.
2
Dietary modifications for infantile colic.婴儿腹绞痛的饮食调整
Cochrane Database Syst Rev. 2018 Oct 10;10(10):CD011029. doi: 10.1002/14651858.CD011029.pub2.
3
Effect of lactase supplementation on infant colic: Systematic review of randomized controlled trials.补充乳糖酶对婴儿腹绞痛的影响:随机对照试验的系统评价
J Pediatr Gastroenterol Nutr. 2024 May;78(5):1009-1016. doi: 10.1002/jpn3.12144. Epub 2024 Mar 1.
4
Oral lactase for infantile colic: a randomized double-blind placebo-controlled trial.口服乳糖酶治疗婴儿绞痛:一项随机双盲安慰剂对照试验。
BMC Pediatr. 2022 Aug 3;22(1):468. doi: 10.1186/s12887-022-03531-8.
5
Manipulative therapies for infantile colic.婴儿腹绞痛的手法治疗
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD004796. doi: 10.1002/14651858.CD004796.pub2.
6
Probiotics to prevent infantile colic.预防婴儿腹绞痛的益生菌。
Cochrane Database Syst Rev. 2019 Mar 13;3(3):CD012473. doi: 10.1002/14651858.CD012473.pub2.
7
Evaluating the impact of lactase supplementation on infant colic: Study protocol for a systematic review of randomized controlled trials.评估乳糖酶补充剂对婴儿腹绞痛的影响:一项随机对照试验系统评价的研究方案。
JPGN Rep. 2024 Jan 23;5(1):5-9. doi: 10.1002/jpr3.12024. eCollection 2024 Feb.
8
Clinical Efficacy Of Lactase Enzyme Supplement In Infant Colic: A Randomised Controlled Trial.乳糖酶补充剂治疗婴儿腹绞痛的临床疗效:一项随机对照试验
J Pak Med Assoc. 2018 Dec;68(12):1744-1747.
9
Parent training programmes for managing infantile colic.管理婴儿腹绞痛的家长培训项目。
Cochrane Database Syst Rev. 2019 Dec 3;12(12):CD012459. doi: 10.1002/14651858.CD012459.pub2.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.